Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib‐resistantBRAFV600Emutation bearing metastatic melanoma cells-Reference-Cited by-同舟云学术

Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib‐resistantBRAFV600Emutation bearing metastatic melanoma cells

Published:2019-06-18 Issue:9 Volume:58 Page:1680-1690
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol Carcinog

Author:

Carpenter Evan L.¹²,Chagani Sharmeen¹,Nelson Dylan¹,Cassidy Pamela B.²³,Laws Madeleine²,Ganguli‐Indra Gitali¹³,Indra Arup K.¹²⁴⁵³^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, College of PharmacyOregon State University Corvallis Oregon

2. Department of DermatologyOregon Health & Science University Portland Oregon

3. Knight Cancer InstituteOregon Health & Science University Portland Oregon

4. Department of Biochemistry and BiophysicsOSU Corvallis Oregon

5. Linus Pauling InstituteOregon State University Corvallis Oregon

Funder

National Institute of Environmental Health Sciences

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23068

Reference38 articles.

1. Melanoma: from mutations to medicine

2. From melanocytes to melanomas

3. BrafV600E cooperates with Pten loss to induce metastatic melanoma

4. Analysis of N- and K-Ras Mutations in the Distinctive Tumor Progression Phases of Melanoma

5. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria and potential of mitochondria-targeted therapy in BRAF mutant cancer: A review;Critical Reviews in Oncology/Hematology;2024-11

2. Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway;Cancer Management and Research;2024-05

3. Mitochondria act as a key regulatory factor in cancer progression: Current concepts on mutations, mitochondrial dynamics, and therapeutic approach;Mutation Research - Reviews in Mutation Research;2024-01

4. Mitochondrion: Main organelle in orchestrating cancer escape from chemotherapy;Cancer Reports;2023-12-27

5. PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism;Frontiers in Oncology;2023-07-18